A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®
Clinical trial NCT00920647 · COMPLETED
Trial details
- NCT number
- NCT00920647
- Sponsor
- Shire
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-18
- Primary completion
- 2012-10-29
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.